Bao-Shan Hu

Bao-Shan Hu


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2022 in World Neurosurgery
Verified
Journal Article
Closed access
GLGuang-Xun Lin
Guang-Xun Lin
ZYZhi-Kang Yao
Zhi-Kang Yao
XZXiaonong Zhang
Xiaonong Zhang
CCChien-Min Chen
Chien-Min Chen
GRGang Rui
Gang Rui
BHBao-Shan Hu
Bao-Shan Hu

10 August 2022 in Frontiers in Surgery
Verified
Journal Article
Open access
GLGuang-Xun Lin
Guang-Xun Lin
JKJin-Sung Kim
Jin-Sung Kim
VKVit Kotheeranurak
Vit Kotheeranurak
Chien-Min ChenChien-Min Chen
Chien-Min Chen
BHBao-Shan Hu
Bao-Shan Hu
GRGang Rui
Gang Rui
Purpose: This study aimed to provide a direct meta-analysis of the evidence comparing outcomes between expandable cages and static cages in patients with transforaminal lumbar interbody fusion (TLIF).Methods: A search of relevant materials from databases was performed from inception to March 7, 2022. Clinical and radiological outcomes were included.Results: Ten studies (1,440 patients) were included. The anterior disc height and foraminal height for expandable cages were substantially higher than those for static cages at the final follow-up (P < 0.0001; P = 0.05). In comparison with static cages, although not statistically significant, expandable cages showed beneficial results, including an increase in posterior disc height and segmental lordosis. There were no statistically significant differences in segmental lordosis, lumbar lordosis, pelvic parameters, cage subsidence, or fusion rates (P > 0.05). Oswestry disability index scores for expandable cages were substantially lower than those for static cages at the final follow-up (P = 0.0007). Interestingly, although the preoperative visual analog scores for back and leg pain were significantly higher in the expandable group than in the static group (P < 0.0001; P = 0.008), there was no significant difference between the static and expandable groups during the final follow-up (P = 0.51; P = 0.85).Conclusions: Expandable cages are associated with improved functional outcomes and restored postoperative disc and foraminal heights in patients with TLIF. In addition, no statistically significant differences were observed in segmental lordosis, lumbar lordosis, pelvic parameters, cage subsidence, or fusion rate.

31 January 2022 in International Orthopaedics
Verified
Journal Article
Closed access
PDF file
GLGuang-Xun Lin
Guang-Xun Lin
JNJin-Niang Nan
Jin-Niang Nan
KCKuo-Tai Chen
Kuo-Tai Chen
LSLi-Wei Sun
Li-Wei Sun
CTChing-Ting Tai
Ching-Ting Tai
BHBao-Shan Hu
Bao-Shan Hu

23 September 2022 in Frontiers in Surgery
Verified
Journal Article
Open access
GLGuang-Xun Lin
Guang-Xun Lin
ZYZhi-Kang Yao
Zhi-Kang Yao
CXChen Xin
Chen Xin
JKJin-Sung Kim
Jin-Sung Kim
Chien-Min ChenChien-Min Chen
Chien-Min Chen
BHBao-Shan Hu
Bao-Shan Hu
Osbjective: Several studies have shown that both microscopic unilateral laminotomy bilateral decompression (ULBD) and unilateral biportal endoscopic (UBE) ULBD are effective for treating lumbar canal stenosis (LCS). However, there are different viewpoints as to which surgical technique is superior. Therefore, this meta-analysis investigated the clinical efficacy and side effects of microscopic ULBD and UBE ULBD for treating LCS.Methods: To identify relevant studies describing the clinical outcomes and complication rates of microscopic ULBD and UBE ULBD for LCS, several databases were systematically searched in the Internet. The visual analog scale score for back and leg pain and the Oswestry Disability Index were used to assess clinical outcomes. Furthermore, data about perioperative outcomes and complications were documented.Results: In total, six studies with 450 participants were included in this meta-analysis. The UBE ULBD was found to be superior to microscopic ULBD in terms of efficacy against early postoperative back and leg pain. However, there was no significant difference between the two procedures in terms of final clinical outcomes and complications. In addition, compared with microscopic ULBD, UBE ULBD was associated with a significant reduction in the length of hospital stay and C-reactive protein levels 2 days after surgery.Conclusion: UBE ULBD and microscopic ULBD for the treatment of LCS were similar in terms of final clinical outcomes and complications. However, UBE ULBD has several advantages over microscopic ULBE, including a shorter hospital stay and faster alleviation of postoperative back and leg pain.

15 September 2022 in European Spine Journal
Verified
Journal Article
Closed access
PDF file
GLGuang-Xun Lin
Guang-Xun Lin
Chien-Min ChenChien-Min Chen
Chien-Min Chen
GRGang Rui
Gang Rui
BHBao-Shan Hu
Bao-Shan Hu

7 November 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
XYXiwen Yuan
Xiwen Yuan
PYPeiyan Yang
Peiyan Yang
JHJiapeng Hu
Jiapeng Hu
DCDixin Cai
Dixin Cai
BHBao-Shan Hu
Bao-Shan Hu
ZLZhiming Lin
Zhiming Lin
Background: Autoimmune diseases (ADs) are a category of conditions characterized by misrecognition of autologous tissues and organs by the immune system, leading to severe impairment of patients’ health and quality of life. Increasing evidence suggests a connection between fluctuations in plasma metabolites and ADs. However, the existence of a causal relationship behind these associations remains uncertain.Methods: Applying the two-sample mendelian randomization (MR) method, the reciprocal causality between plasma metabolites and ADs was analyzed. We took the intersection of two metabolite genome-wide association study (GWAS) datasets for GWAS-meta and obtained 1,009 metabolites’ GWAS data using METAL software. We accessed GWAS summary statistics for 5 common ADs, inflammatory bowel disease (IBD), multiple sclerosis (MS), type 1 diabetes (T1D), systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) from published GWAS data. MR analyses were performed in discovery and replication stage simultaneously. Meanwhile, the reverse MR analysis was conducted to investigate the possibility of reverse causal association. Furthermore, a series of sensitivity analyses were conducted to validate the robustness of the results. These statistical analyses were conducted using R software. Finally, the web version of MetaboAnalyst 5.0. was applied to analyze metabolic pathways. Ultimately, we conducted ELISA assays on plasma samples from patients to validate the results.Results: 4 metabolites were identified to have causal relationships with IBD, 2 metabolites with MS, 13 metabolites with RA, and 4 metabolites with T1D. In the reverse MR analysis, we recognized causality between SLE and 22 metabolites, IBD and 4 metabolites, RA and 22 metabolites, and T1D and 37 metabolites. Additionally, 4 significant metabolic pathways were identified in RA by metabolic pathway analysis in the forward MR analysis. Correspondingly, in the reverse, 11 significant metabolic pathways in RA, 8 in SLE, and 4 in T1D were obtained using identical approaches. Furthermore, the protective role of glutamate was confirmed through ELISA assays.Conclusions: Our research established a reciprocal causality between plasma metabolites and ADs. Furthermore, diverse metabolic pathways correlated with ADs were uncovered. Novel insights into the prediction and diagnosis were provided, as well as new targets for precise treatment of these conditions were discovered.